Tong Yaw-Chong, Chang Shwu-Fen, Liu Chia-Yang, Kao Winston W-Y, Huang Chong Heng, Liaw Jiahorng
College of Pharmacy, Taipei Medical University, Taipei, Taiwan.
J Gene Med. 2007 Nov;9(11):956-66. doi: 10.1002/jgm.1093.
This study evaluates the eye drop delivery of genes with cornea-specific promoters, i.e., keratin 12 (K12) and keratocan (Kera3.2) promoters, by non-ionic poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) (PEO-PPO-PEO) polymeric micelles (PM) to mouse and rabbit eyes, and investigates the underlying mechanisms.
Three PM-formulated plasmids (pCMV-Lac Z, pK12-Lac Z and pKera3.2-Lac Z) containing the Lac Z gene for beta-galactosidase (beta-Gal) whose expression was driven by the promoter of either the cytomegalovirus early gene, the keratin 12 gene or the keratocan gene, were characterized by critical micelle concentration (CMC), dynamic light scattering (DLS), and atomic force microscopy (AFM). Transgene expression in ocular tissue after gene delivery was analyzed by 5-bromo-4-chloro-3-indolyl-beta-D-galactoside (X-Gal) color staining, 1,2-dioxetane beta-Gal enzymatic activity measurement, and real-time polymerase chain reaction (PCR) analysis. The delivery mechanisms of plasmid-PM on mouse and rabbit corneas were evaluated by EDTA and RGD (arginine-glycine-aspartic acid) peptide.
The sizes of the three plasmid-PM complexes were around 150-200 nm with unimodal distribution. Enhanced stability was found for three plasmid-PM formulations after DNase I treatment. After six doses of eye drop delivery of pK12-Lac Z-PM three times a day, beta-Gal activity was significantly increased in both mouse and rabbit corneas. Stroma-specific Lac Z expression was only found in pKera3.2-Lac Z-PM-treated animals with pretreatment by 5 mM EDTA, an opener of junctions. Lac Z gene expression in both pK12-Lac Z-PM and pKera3.2-Lac Z-PM delivery groups was decreased by RGD peptide pretreatment.
Cornea epithelium- and stroma-specific gene expression could be achieved using cornea-specific promoters of keratin 12 and keratocan genes, and the gene was delivered with PM formulation through non-invasive, eye drop in mice and rabbits. The transfection mechanism of plasmid-PM may involve endocytosis and particle size dependent paracellular transport.
本研究评估了使用非离子型聚(环氧乙烷)-聚(环氧丙烷)-聚(环氧乙烷)(PEO-PPO-PEO)聚合物胶束(PM)将具有角膜特异性启动子,即角蛋白12(K12)和角膜蛋白聚糖(Kera3.2)启动子的基因滴眼递送至小鼠和兔眼,并研究其潜在机制。
三种含有用于β-半乳糖苷酶(β-Gal)的Lac Z基因的PM制剂质粒(pCMV-Lac Z、pK12-Lac Z和pKera3.2-Lac Z),其表达分别由巨细胞病毒早期基因、角蛋白12基因或角膜蛋白聚糖基因的启动子驱动,通过临界胶束浓度(CMC)、动态光散射(DLS)和原子力显微镜(AFM)进行表征。基因递送后眼组织中的转基因表达通过5-溴-4-氯-3-吲哚基-β-D-半乳糖苷(X-Gal)染色、1,2-二氧杂环丁烷β-Gal酶活性测定和实时聚合酶链反应(PCR)分析进行。通过乙二胺四乙酸(EDTA)和RGD(精氨酸-甘氨酸-天冬氨酸)肽评估质粒-PM在小鼠和兔角膜上的递送机制。
三种质粒-PM复合物的大小约为150-200nm,呈单峰分布。DNase I处理后,三种质粒-PM制剂的稳定性增强。每天三次滴眼给予六剂pK12-Lac Z-PM后,小鼠和兔角膜中的β-Gal活性均显著增加。仅在使用5mM EDTA(一种连接开口剂)预处理的pKera3.2-Lac Z-PM处理的动物中发现了基质特异性Lac Z表达。RGD肽预处理降低了pK12-Lac Z-PM和pKera3.2-Lac Z-PM递送组中的Lac Z基因表达。
使用角蛋白12和角膜蛋白聚糖基因的角膜特异性启动子可实现角膜上皮和基质特异性基因表达,并且该基因通过PM制剂以非侵入性滴眼方式递送至小鼠和兔眼。质粒-PM的转染机制可能涉及内吞作用和粒径依赖性细胞旁转运。